These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25606696)

  • 1. Endogenous carbon monoxide and cardiometabolic risk: can measuring exhaled carbon monoxide be used to refine cardiometabolic risk assessment?
    Nayor M; Vasan RS
    Future Cardiol; 2015; 11(1):9-12. PubMed ID: 25606696
    [No Abstract]   [Full Text] [Related]  

  • 2. Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.
    Cheng S; Lyass A; Massaro JM; O'Connor GT; Keaney JF; Vasan RS
    Circulation; 2010 Oct; 122(15):1470-7. PubMed ID: 20876437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special issue on carbon monoxide and exhaled biomarkers in human disease.
    Ryter SW
    J Breath Res; 2010 Dec; 4(4):040201. PubMed ID: 21383483
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of exhaled carbon monoxide and carbon dioxide during lung cancer operation.
    Khasag N; Sakiyama S; Toba H; Yoshida M; Nakagawa Y; Takizawa H; Kawakami Y; Kenzaki K; Ali AH; Kondo K; Tangoku A
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):531-6. PubMed ID: 23913245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of biochemical liver markers, physical activity, fitness and body mass index for a cardiometabolic risk model in childhood.
    Konidari A; Auth MK; Murphy MH; Cunningham C; Foweather L; Gobbi R; Graves LE; Hopkins ND; Stratton G; Boddy LM
    Acta Paediatr; 2014 May; 103(5):e194-8. PubMed ID: 24512112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
    Billups KL; Miner MM; Wierzbicki AS; Jackson G
    Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic status, metabolic syndrome, and cardiovascular risk in children.
    Berenson GS; Agirbasli M; Nguyen QM; Chen W; Srinivasan SR
    Med Clin North Am; 2011 Mar; 95(2):409-17, ix. PubMed ID: 21281842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Sowers JR
    J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosgene- and chlorine-induced acute lung injury in rats: comparison of cardiopulmonary function and biomarkers in exhaled breath.
    Luo S; Trübel H; Wang C; Pauluhn J
    Toxicology; 2014 Dec; 326():109-18. PubMed ID: 25456270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids and the cardiometabolic syndrome.
    Juturu V
    J Cardiometab Syndr; 2008; 3(4):244-53. PubMed ID: 19040594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of estrogen in the control of cardiometabolic disease.
    Cignarella A; Kratz M; Bolego C
    Trends Pharmacol Sci; 2010 Apr; 31(4):183-9. PubMed ID: 20138672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing risk across the spectrum of patients with the metabolic syndrome.
    Rosenson RS
    Am J Cardiol; 2005 Aug; 96(4A):8E-10E. PubMed ID: 16098836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
    Barnett AH
    Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoprovocation testing in asthma: effect on exhaled monoxides.
    Sethi JM; White AM; Patel SA; Dinella JV; Calhoun WJ; Choi AM
    J Breath Res; 2010 Dec; 4(4):047104. PubMed ID: 21383491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
    Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
    J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 17. Measuring biomarkers to assess the therapeutic effects of PPAR agonists?
    Chinetti-Gbaguidi G; Staels B
    Pharmacogenomics; 2007 Nov; 8(11):1567-80. PubMed ID: 18034622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ventilation on the collection of exhaled breath in humans.
    Cope KA; Watson MT; Foster WM; Sehnert SS; Risby TH
    J Appl Physiol (1985); 2004 Apr; 96(4):1371-9. PubMed ID: 14672964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of exhaled breath condensate biomarkers after fractionated collection based on exhaled CO2 signal.
    Goldoni M; Corradi M; Mozzoni P; Folesani G; Alinovi R; Pinelli S; Andreoli R; Pigini D; Tillo R; Filetti A; Garavelli C; Mutti A
    J Breath Res; 2013 Mar; 7(1):017101. PubMed ID: 23445573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.